The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
Abstract Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived product...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-10-01
|
| Series: | Virology Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12985-023-02183-z |
| _version_ | 1827724667530510336 |
|---|---|
| author | Amirhosein Faghihkhorasani Hanan Hassan Ahmed Noor Muhammad Mashool Mariem Alwan Marjan Assefi Aya Hussein Adab Saman Yasamineh Omid Gholizadeh Moein Baghani |
| author_facet | Amirhosein Faghihkhorasani Hanan Hassan Ahmed Noor Muhammad Mashool Mariem Alwan Marjan Assefi Aya Hussein Adab Saman Yasamineh Omid Gholizadeh Moein Baghani |
| author_sort | Amirhosein Faghihkhorasani |
| collection | DOAJ |
| description | Abstract Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. Graphical Abstract |
| first_indexed | 2024-03-10T22:18:04Z |
| format | Article |
| id | doaj.art-153395b891f145359be00d681b504d8c |
| institution | Directory Open Access Journal |
| issn | 1743-422X |
| language | English |
| last_indexed | 2024-03-10T22:18:04Z |
| publishDate | 2023-10-01 |
| publisher | BMC |
| record_format | Article |
| series | Virology Journal |
| spelling | doaj.art-153395b891f145359be00d681b504d8c2023-11-19T12:21:25ZengBMCVirology Journal1743-422X2023-10-0120112710.1186/s12985-023-02183-zThe potential use of bacteria and bacterial derivatives as drug delivery systems for viral infectionAmirhosein Faghihkhorasani0Hanan Hassan Ahmed1Noor Muhammad Mashool2Mariem Alwan3Marjan Assefi4Aya Hussein Adab5Saman Yasamineh6Omid Gholizadeh7Moein Baghani8Medical Student, Iran University of Medical SciencesDepartment of Pharmacy, Al-Noor University CollegeCollege of Nursing, National University of Science and TechnologyPharmacy College, Al-Farahidi UniversityUniversity of North Carolina at GreensboroDepartment of Pharmacy, Al-Zahrawi University CollegeYoung Researchers and Elite Club, Tabriz Branch, Islamic Azad UniversityResearch Center for Clinical Virology, Tehran University of Medical SciencesSkin Research Center, Shahid Beheshti University of Medical SciencesAbstract Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. Graphical Abstracthttps://doi.org/10.1186/s12985-023-02183-zDrug delivery systemVaccineBacteriaBacterial derivativesViral infection |
| spellingShingle | Amirhosein Faghihkhorasani Hanan Hassan Ahmed Noor Muhammad Mashool Mariem Alwan Marjan Assefi Aya Hussein Adab Saman Yasamineh Omid Gholizadeh Moein Baghani The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection Virology Journal Drug delivery system Vaccine Bacteria Bacterial derivatives Viral infection |
| title | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| title_full | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| title_fullStr | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| title_full_unstemmed | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| title_short | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| title_sort | potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
| topic | Drug delivery system Vaccine Bacteria Bacterial derivatives Viral infection |
| url | https://doi.org/10.1186/s12985-023-02183-z |
| work_keys_str_mv | AT amirhoseinfaghihkhorasani thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT hananhassanahmed thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT noormuhammadmashool thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT mariemalwan thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT marjanassefi thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT ayahusseinadab thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT samanyasamineh thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT omidgholizadeh thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT moeinbaghani thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT amirhoseinfaghihkhorasani potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT hananhassanahmed potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT noormuhammadmashool potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT mariemalwan potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT marjanassefi potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT ayahusseinadab potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT samanyasamineh potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT omidgholizadeh potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT moeinbaghani potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection |